Search research articles
Contact Us
Filters
Showing results (1-10 of 20) with videos related to
Page
of 2
Sort By:
Cancer Medicine
|
March 16, 2018
International trends in lung cancer incidence from 1973 to 2007
Yue Zhang, Jian-Song Ren, Hui-Yao Huang, et al.
Human Vaccines & Immunotherapeutics
|
July 13, 2021
Landscape and progress of global COVID-19 vaccine development
Hui-Yao Huang, Shu-Hang Wang, Yu Tang, et al.
BMC Medical Education
|
June 14, 2023
Integrating China in the international consortium for personalised medicine. a position paper on healthcare professionals' education and citizens' empowerment in personalised medicine
Flavia Beccia, Francesco Andrea Causio, Ilda Hoxhaj, et al.
Public Health Genomics
|
December 7, 2023
Integrating China in the International Consortium for Personalized Medicine: A Position Paper on Personalized Medicine in Sustainable Healthcare
Francesco Andrea Causio, Flavia Beccia, Ilda Hoxhaj, et al.
Journal of Hematology & Oncology
|
July 18, 2023
Clinical development of mRNA therapies against solid tumors
Dawei Wu, Lingfeng Hu, Xin Wang, et al.
Military Medical Research
|
March 11, 2026
Target trial emulation in oncology: current use and future directions
Hui-Yao Huang, Le Wang, Sheng Xu, et al.
Tobacco Control
|
May 11, 2019
Economic burden of lung cancer attributable to smoking in China in 2015
Ju-Fang Shi, Cheng-Cheng Liu, Jian-Song Ren, et al.
Frontiers in Pharmacology
|
February 4, 2021
Pharmacoeconomic Evaluation of Cancer Biosimilars Worldwide: A Systematic Review
Hui-Yao Huang, Cheng-Cheng Liu, Yue Yu, et al.
The Lancet. Oncology
|
November 2, 2019
Changes in clinical trials of cancer drugs in mainland China over the decade 2009-18: a systematic review
Ning Li, Hui-Yao Huang, Da-Wei Wu, et al.
BMJ Open
|
June 4, 2021
Platform study of genotyping-guided precision medicine for rare solid tumours: a study protocol for a phase II, non-randomised, 18-month, open-label, multiarm, single-centre clinical trial testing the safety and efficacy of multiple Chinese-approved targeted drugs and PD-1 inhibitors in the treatment of metastatic rare tumours
Shuhang Wang, Hui-Yao Huang, Dawei Wu, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 20) with videos related to
Sort By:
Page
of 2
Cancer Medicine
|
March 16, 2018
International trends in lung cancer incidence from 1973 to 2007
Yue Zhang, Jian-Song Ren, Hui-Yao Huang, et al.
Human Vaccines & Immunotherapeutics
|
July 13, 2021
Landscape and progress of global COVID-19 vaccine development
Hui-Yao Huang, Shu-Hang Wang, Yu Tang, et al.
BMC Medical Education
|
June 14, 2023
Integrating China in the international consortium for personalised medicine. a position paper on healthcare professionals' education and citizens' empowerment in personalised medicine
Flavia Beccia, Francesco Andrea Causio, Ilda Hoxhaj, et al.
Public Health Genomics
|
December 7, 2023
Integrating China in the International Consortium for Personalized Medicine: A Position Paper on Personalized Medicine in Sustainable Healthcare
Francesco Andrea Causio, Flavia Beccia, Ilda Hoxhaj, et al.
Journal of Hematology & Oncology
|
July 18, 2023
Clinical development of mRNA therapies against solid tumors
Dawei Wu, Lingfeng Hu, Xin Wang, et al.
Military Medical Research
|
March 11, 2026
Target trial emulation in oncology: current use and future directions
Hui-Yao Huang, Le Wang, Sheng Xu, et al.
Tobacco Control
|
May 11, 2019
Economic burden of lung cancer attributable to smoking in China in 2015
Ju-Fang Shi, Cheng-Cheng Liu, Jian-Song Ren, et al.
Frontiers in Pharmacology
|
February 4, 2021
Pharmacoeconomic Evaluation of Cancer Biosimilars Worldwide: A Systematic Review
Hui-Yao Huang, Cheng-Cheng Liu, Yue Yu, et al.
The Lancet. Oncology
|
November 2, 2019
Changes in clinical trials of cancer drugs in mainland China over the decade 2009-18: a systematic review
Ning Li, Hui-Yao Huang, Da-Wei Wu, et al.
BMJ Open
|
June 4, 2021
Platform study of genotyping-guided precision medicine for rare solid tumours: a study protocol for a phase II, non-randomised, 18-month, open-label, multiarm, single-centre clinical trial testing the safety and efficacy of multiple Chinese-approved targeted drugs and PD-1 inhibitors in the treatment of metastatic rare tumours
Shuhang Wang, Hui-Yao Huang, Dawei Wu, et al.
Page
of 2